Vaccine News and Research

Latest Vaccine News and Research

Dr Lluis Quintana-Murci from the Institut Pasteur in France honoured with the Debiopharm Life Sciences Award

Debiopharm Group, SA (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today presented the 'Debiopharm Life Sciences Award' to Dr Lluis Quintana-Murci from the Institut Pasteur in France, for his outstanding innovative research in the emerging field of evolutionary genetics of infection.

4 Sep 2009

HTDS announces closure of Regulation D 504 offering

Hard to Treat Diseases (the "Company") (HTDS.PK) announced today that it has closed its Regulation D, Rule 504 offering and is no longer selling shares of its common stock to accredited investors.

4 Sep 2009

Department of Health's guidance on swine flu vaccination leaves local health chiefs confused

Thousands of frontline health workers in England are trapped in a postcode lottery after Department of Health (DH) guidance on swine flu vaccination has left local health chiefs confused over who is eligible for the jab.

4 Sep 2009

Media examine debate over UNESCO international sex education guidelines

The New York Times examines how "[a] set of proposed international sex education guidelines aimed at reducing H.I.V. infections among young people" and unplanned pregnancies, based on "more than 80 studies of sex education," has received some criticism. The release of the final guidelines, originally scheduled for next week by the United Nations Educational, Scientific and Cultural Organization (UNESCO), has been delayed.

4 Sep 2009

Upgraded Upp Technology irms|EM software streamlines H1N1 vaccine distribution

Based on feedback from their national client base of Public Health Agencies and First Responders, Upp Technology has added significant enhancements to its already award winning irms|EM (Emergency Management) software. The new irms|EM product enhancements streamline the order fulfillment and distribution process of H1N1 vaccines and Personal Protective Equipment (PPE) to partner agencies, private facilities, as well as, the general public.

4 Sep 2009

Clinical trial of Novartis MF59 swine-flu vaccine elicits a strong immune response

Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.

4 Sep 2009

SFDA approves production license for Sinovac's H1N1 vaccine

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the State Food and Drug Administration (SFDA) has approved the registration application for PANFLU.1, Sinovac's H1N1 vaccine, and has issued Sinovac a production license for this vaccine.

4 Sep 2009

New center to study mathematical modeling of drug resistance and internention to be established at HSPH

A new center that will focus on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health (HSPH).

4 Sep 2009

Genetic cause of progressive hearing loss discovered

A team led by scientists from The Scripps Research Institute has discovered a genetic cause of progressive hearing loss. The findings will help scientists better understand the nature of age-related decline in hearing and may lead to new therapies to prevent or treat the condition.

4 Sep 2009

Two new antibodies for targeting HIV virus discovered

Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram Biosciences have discovered two powerful new antibodies to HIV that reveal what may be an Achilles heel on the virus. They published their work in Science this week.

3 Sep 2009

H1N1 vaccine to cost countries $2.50 - $20 per dose

The H1N1 (swine) flu vaccine will cost countries between $2.50 and $20 per dose, based on their ability to pay, according to the director of the Initiative for Vaccine Research at the WHO, Marie-Paule Kieny, Agence France-Presse/Khaleej Times reports. During an interview published in the September issue of the WHO Bulletin, Kieny "also warned that there would not be enough vaccines for the world's population and that people should not rely entirely on the vaccine," the news service writes (9/2).

3 Sep 2009

CDC recommends routine health examintion for all school-age children

Although school has just begun, it is already exam time for students throughout Wisconsin. That's because in addition to notebook paper and pens, back-to-school preparations should also include routine health exams to make sure students are healthy and ready to learn. These include: a doctor's exam to confirm that all immunizations are up-to-date, a dental exam and a vision exam.

3 Sep 2009

Biosante and Cell Genesys to merge after stockholders' approval

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.

3 Sep 2009

Biosante Pharmaceuticals and Cell Genesys to hold stockholders meeting for merger approval

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc. (NASDAQ:CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies.

3 Sep 2009

U.S. Department of Health and Human Services to purchase flu products from BD

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has received a significant order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) for the purchase of syringes and needles, sharps collectors and alcohol swabs to be used in national flu pandemic preparedness efforts.

From BD (Becton, Dickinson and Company) 3 Sep 2009

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

For economists and policy-makers to understand the true value of the costs and savings of preventive health programs for chronic disease, the Congressional Budget Office (CBO) should incorporate long-term clinical outcomes data and look beyond the 10-year window when making cost estimates, says a team of University of Chicago researchers in today's issue of Health Affairs.

3 Sep 2009

Study assesses protective capabilities of DNA vaccines against SIV

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that data generated from a pre-clinical collaborative study by National Cancer Institute (NCI) and Inovio scientists were published in the scientific journal Proceedings of the National Academy of Sciences in a paper entitled: “DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge.”

3 Sep 2009

Seasonal flu vaccinations increases by 237% this season compared to the same four weeks during last season

According to SDI, a leading healthcare market insight and analytics firm that consolidates electronic healthcare claims data, there have been over 477,000 seasonal flu vaccinations already administered through Aug. 29 — the fourth week of this year’s flu season. That is an increase of 237% compared to the same four weeks during last season.

3 Sep 2009

First swine-flu vaccine trials reveal strong immune response

Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.

3 Sep 2009

Biosante's CEO to present an overview of the company and its impending merger with Cell Genesys

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO will present an overview of the company and its impending merger with Cell Genesys (NASDAQ: CEGE) at two healthcare investment and partnering conferences during the month of September.

3 Sep 2009

Vaccine News and Research

Latest Vaccine News and Research

Dr Lluis Quintana-Murci from the Institut Pasteur in France honoured with the Debiopharm Life Sciences Award

HTDS announces closure of Regulation D 504 offering

Department of Health's guidance on swine flu vaccination leaves local health chiefs confused

Media examine debate over UNESCO international sex education guidelines

Upgraded Upp Technology irms|EM software streamlines H1N1 vaccine distribution

Clinical trial of Novartis MF59 swine-flu vaccine elicits a strong immune response

SFDA approves production license for Sinovac's H1N1 vaccine

New center to study mathematical modeling of drug resistance and internention to be established at HSPH

Genetic cause of progressive hearing loss discovered

Two new antibodies for targeting HIV virus discovered

H1N1 vaccine to cost countries $2.50 - $20 per dose

CDC recommends routine health examintion for all school-age children

Biosante and Cell Genesys to merge after stockholders' approval

Biosante Pharmaceuticals and Cell Genesys to hold stockholders meeting for merger approval

U.S. Department of Health and Human Services to purchase flu products from BD

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

Study assesses protective capabilities of DNA vaccines against SIV

Seasonal flu vaccinations increases by 237% this season compared to the same four weeks during last season

First swine-flu vaccine trials reveal strong immune response

Biosante's CEO to present an overview of the company and its impending merger with Cell Genesys

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in